Healthpeak Properties (DOC) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jan, 2026Executive summary
Achieved strong operational performance in 2024, with successful merger integration, internalization, leasing, and senior housing operations driving growth.
FFO per share grew 12% and AFFO per share 19% over the past three years, with further growth implied in 2025 guidance.
Completed merger with Physicians Realty Trust, creating a leading outpatient platform with nearly 50 million square feet and realizing $50M in synergies in 2024.
Increased dividend, now paid monthly starting April 2025, supported by earnings growth and a conservative FFO payout ratio.
Leadership transitions and promotions announced to strengthen the executive team, including Kelvin Moses and Tracy Porter.
Financial highlights
Q4 2024: FFOs adjusted $0.46/share, AFFO $0.40/share, same-store growth 5.4%.
Full year 2024: FFOs adjusted $1.81/share, AFFO $1.60/share, same-store growth 5.4%.
Exceeded midpoint of original FFOs adjusted guidance by $0.05.
Net debt to EBITDA at 5.2x at year-end, providing ample capacity for investments.
Closed $1.3B in asset sales at a 6.4% cap rate, resulting in an under-levered balance sheet.
Outlook and guidance
2025 FFOs adjusted guidance: $1.81–$1.87/share; diluted EPS $0.30–$0.36.
Total same-store growth forecasted at 3–4%: outpatient medical 2.5–3.5%, lab 3–4%, CCRCs 4–8%.
$500 million of investments included in guidance, with a robust pipeline and weighted average yield of 8%+.
Capital spend forecasted at $600 million, focused on development and redevelopment.
2025 guidance excludes $0.04 of FFO from signed but not yet occupied leases, which will benefit earnings in late 2025.
Latest events from Healthpeak Properties
- Key votes include board elections, executive pay approval, and auditor ratification for 2026.DOC
Proxy Filing12 Mar 2026 - 2025 saw strong results, board refreshment, and enhanced ESG, with key votes on directors, pay, and auditor.DOC
Proxy Filing12 Mar 2026 - Janus Living IPO and operational efficiencies position Healthpeak for growth in core healthcare real estate.DOC
Citi’s Miami Global Property CEO Conference 20263 Mar 2026 - Janus Living IPO, $600M biotech campus acquisition, and $1B capital recycling drive growth.DOC
Investor presentation3 Mar 2026 - 2026 guidance anticipates a bottom in FFO, with growth expected as lab and senior housing recover.DOC
Q4 20253 Feb 2026 - Q2 net income surged, guidance raised, and $1.2B in asset sales completed.DOC
Q2 20242 Feb 2026 - Merger-driven scale, strong leasing, and robust financials support optimistic growth outlook.DOC
Nareit REIT Week: 2024 Investor Conference31 Jan 2026 - Q3 2024 saw strong leasing, NOI growth, and higher guidance, fueled by merger synergies.DOC
Q3 202418 Jan 2026 - Outpatient and life science platforms drive growth, with lab supply peaking and CCRC margins rising.DOC
Citi’s 30th Annual Global Property CEO Conference 20257 Jan 2026